Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FFNP PET/MR Imaging in Invasive Breast Cancer
NCT03212170Phase 2Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Dec 2017
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluorofuranylnorprogesterone in Invasive breast cancer (IBC), sponsored by University of Wisconsin–Madison. Started Dec 2017; status: completed.
02
Drugs
fluorofuranylnorprogesterone
03
Conditions
Invasive breast cancer (IBC)
Beyond the preview
Go deeper on NCT03212170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03212170.